Displaying drugs 6001 - 6025 of 9307 in total
Lithium succinate
Experimental
LY3884961
LY3884961 (previously PR001) is being developed by Prevail Therapeutics as a single-dose gene therapy for patients with Parkinson's disease and Gaucher disease.
Investigational
(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide
Experimental
Matched Name: … (S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide …
Matched Iupac: … {[(1S)-1-{[(1S)-3-methyl-1-[(4-nitrophenyl)carbamoyl]butyl]carbamoyl}pentyl]oxy}phosphonic acid …
Matched Iupac: … {[(1S)-1-{[(1S)-3-methyl-1-[(4-nitrophenyl)carbamoyl]butyl]carbamoyl}pentyl]oxy}phosphonic acid …
Labetuzumab govitecan
Labetuzumab govitecan has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, and Metastatic Colorectal Cancer.
Investigational
2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One
Experimental
Matched Name: … 2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One …
Matched Iupac: … 2,6-diamino-8-[(1H-imidazol-2-ylsulfanyl)methyl]-3,4-dihydroquinazolin-4-one …
Matched Iupac: … 2,6-diamino-8-[(1H-imidazol-2-ylsulfanyl)methyl]-3,4-dihydroquinazolin-4-one …
5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine
Experimental
Matched Name: … 5,10,15,20-Tetrakis(4-Sulpfonatophenyl)-21h,23h-Porphine …
Matched Iupac: … [4-(17-{4-[dihydroxy(oxido)-lambda4-sulfanyl]phenyl}-7,12-bis[4-(trihydroxy-lambda4-sulfanyl)phenyl]- …
Matched Iupac: … [4-(17-{4-[dihydroxy(oxido)-lambda4-sulfanyl]phenyl}-7,12-bis[4-(trihydroxy-lambda4-sulfanyl)phenyl]- …
1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea
Experimental
Matched Name: … 1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea …
Matched Iupac: … 3-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-1-(4-chlorophenyl)urea …
Matched Iupac: … 3-(3-tert-butyl-1-methyl-1H-pyrazol-5-yl)-1-(4-chlorophenyl)urea …
4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide
Experimental
Matched Name: … 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide …
Matched Iupac: … 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzene-1-sulfonamide …
Matched Iupac: … 4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzene-1-sulfonamide …
N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA
Experimental
Matched Name: … N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA …
Matched Iupac: … 1-(2-chloro-4-fluorobenzoyl)-3-(5-hydroxy-2-methoxyphenyl)urea …
Matched Iupac: … 1-(2-chloro-4-fluorobenzoyl)-3-(5-hydroxy-2-methoxyphenyl)urea …
[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone
Experimental
Matched Name: … [4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone …
Matched Iupac: … 5-benzoyl-N2-tert-butyl-1,3-thiazole-2,4-diamine …
Matched Iupac: … 5-benzoyl-N2-tert-butyl-1,3-thiazole-2,4-diamine …
Emrusolmin
Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology.
Experimental
Matched Synonyms: … 1H-PYRAZOLE, 3-(1,3-BENZODIOXOL-5-YL)-5-(3-BROMOPHENYL)- ... 3-(1,3-BENZODIOXOL-5-YL)-5-(3-BROMOPHENYL)-1H-PYRAZOLE …
Matched Iupac: … 5-(2H-1,3-benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole …
Matched Iupac: … 5-(2H-1,3-benzodioxol-5-yl)-3-(3-bromophenyl)-1H-pyrazole …
S-Methyl glutathione
Experimental
Matched Synonyms: … L-gamma-Glutamyl-S-methyl-L-cysteinylglycine …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(methylsulfanyl)ethyl]carbamoyl}butanoic acid …
Matched Iupac: … (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(methylsulfanyl)ethyl]carbamoyl}butanoic acid …
Efavaleukin alfa
Efavaleukin alfa is a fusion protein consisting of interleukin mutein fused to the C-terminus of an immunoglobulin G Fc domain by way of a G4S linker. It is under investigation in clinical trial NCT03422627 (Safety and Efficacy of AMG 592 in Subjects With Steroid Refractory Chronic Graft Versus Host Disease).
Investigational
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE
Experimental
Matched Name: … [5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE …
Matched Iupac: … 2-[5-hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-7-yl]acetonitrile …
Matched Iupac: … 2-[5-hydroxy-2-(4-hydroxyphenyl)-1-benzofuran-7-yl]acetonitrile …
N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide
Experimental
Matched Name: … N,4-Dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzenesulfonamide …
Matched Iupac: … N,4-dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzene-1-sulfonamide …
Matched Iupac: … N,4-dimethyl-N-(1-phenyl-1H-pyrazol-5-yl)benzene-1-sulfonamide …
Homoserine Lactone
Experimental
5,7-Dichlorokynurenic acid
Experimental
Matched Iupac: … 5,7-dichloro-4-hydroxyquinoline-2-carboxylic acid …
SB-409513
Experimental
Matched Synonyms: … I-5 …
Matched Iupac: … 2-chloro-5-{[4-(3-chlorophenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]amino}benzoic acid …
Matched Iupac: … 2-chloro-5-{[4-(3-chlorophenyl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl]amino}benzoic acid …
DAS-431 IV
DAS-431 IV is a dopamine D1 receptor agonist developed by DrugAbuse Sciences for the treatment of Addictions, Schizophrenia, Schizoaffective Disorders, Dementia, Parkinson's Disease, Strokes etc.
Investigational
KB407
Investigational
BGB-DXP593
BGB-DXP593 is a SARS-CoV-2 neutralizing antibody. It is currently being investigated against COVID-19 in the clinical trial NCT04551898 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)) by BeiGene.
Investigational
5-Iodo-2'-Deoxyuridine-5'-Monophosphate
Experimental
Matched Name: … 5-Iodo-2'-Deoxyuridine-5'-Monophosphate …
Matched Iupac: … {[(2R,3S,5R)-3-hydroxy-5-(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic …
Matched Iupac: … {[(2R,3S,5R)-3-hydroxy-5-(5-iodo-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy}phosphonic …
hu3S193
Investigational
Quinoline
Investigational
Displaying drugs 6001 - 6025 of 9307 in total